The neutrophil-lymphocyte ratio and its utilisation for the management of cancer patients in early clinical trials.
about
Assessment of a prognostic model, PSA metrics and toxicities in metastatic castrate resistant prostate cancer using data from Project Data Sphere (PDS)Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever.Systemic inflammation is an independent predictive marker of clinical outcomes in mucosal squamous cell carcinoma of the head and neck in oropharyngeal and non-oropharyngeal patients.The Neutrophil-Platelet Score (NPS) Predicts Survival in Primary Operable Colorectal Cancer and a Variety of Common Cancers.Predictive value of pretreatment inflammation-based prognostic scores (neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio) for invasive bladder carcinoma.Preoperative Neutrophil-to-lymphocyte Ratio Predicts Long-term Survival in Patients Undergoing Total Laryngectomy With Advanced Laryngeal Squamous Cell Carcinoma: A Single-center Retrospective Study.Elevated neutrophil to lymphocyte ratio predicts mortality in medical inpatients with multiple chronic conditions.Value of neutrophil-to-lymphocyte ratio for predicting lung cancer prognosis: A meta-analysis of 7,219 patients.Neutrophil-to-lymphocyte ratio as a bladder cancer biomarker: Assessing prognostic and predictive value in SWOG 8710.Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients.Neutrophil to Lymphocyte Ratio, Platelet to Lymphocyte Ratio, Mean Platelet Volume and Red Cell Distribution Width Measures in Bells Palsy.Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin and Neutrophil-Lymphocyte Ratio in Gastric Cancer Patients.Post-treatment neutrophil-to-lymphocyte ratio at week 6 is prognostic in patients with advanced non-small cell lung cancers treated with anti-PD-1 antibody.Pre-operative neutrophil count and neutrophil-lymphocyte count ratio (NLCR) in predicting the histological grade of paediatric brain tumours: a preliminary study.Prognostic role of neutrophil-to-lymphocyte ratio in head and neck cancer: A meta-analysis.Clinical significance of changes in systemic inflammatory markers and carcinoembryonic antigen levels in predicting metastatic colorectal cancer prognosis and chemotherapy response.Systemic inflammation is associated with the density of immune cells in the tumor microenvironment of gastric cancer.Combined analysis of the pre- and postoperative neutrophil-lymphocyte ratio predicts the outcomes of patients with gastric cancer.Comment on "prognostic performance of inflammation-based prognostic indices in patients with resectable colorectal liver metastases".Patterns, predictors and subsequent outcomes of disease progression in metastatic renal cell carcinoma patients treated with nivolumabDelayed adverse events in phase I trials of molecularly targeted and cytotoxic agents
P2860
Q30000285-4271811A-5D1B-4CF8-B108-294EBFF0D0B9Q33845275-23A0EFAB-0ED7-415E-AA4C-FCF91BA48AA0Q35927872-87C98B68-30FF-4A79-B1D6-B6634641C7E3Q36257462-B2E81906-F198-4538-B973-F54CA2108CCCQ36275246-9E68D04E-767F-413A-B11F-CFDC3C9F43CEQ36580936-D0F74B9F-24A3-453D-A25F-114B7FC7385DQ37003669-EFFC428B-2042-449C-A43F-9FE9DCB4E943Q38622803-0AAD2E91-9B1E-4749-A5F7-7842FFF91A37Q39243899-3745EE47-9FD7-4B43-940F-FE7181657849Q40535967-C58B7B44-EAB2-4012-B0E1-D6E81A02B09FQ42320417-7F89312A-4E4C-4C16-81FE-EEA77E01B36BQ47262106-84A36A3E-57E5-47B0-A67B-5D1DD458743BQ47331134-F92FC742-E1D5-4035-8AAD-FFC9B007DA1DQ47393883-BD20A3DE-E53F-4538-B0A4-7E9DC55E815CQ48117100-AD7AD4F1-FDC4-4A46-AAA7-C2E6E727997FQ48167646-B0217A17-76C8-4DF1-B05C-6FA5CCFC3C30Q48336799-477D0057-5936-436E-9279-E176671734FDQ50060426-12FA95F5-21C2-42FE-A4BB-EE2F6DA43679Q53533102-9625B77A-C79D-445B-A21F-3C84350A4473Q58545576-81AB3773-EC8B-4BEF-B6F1-9144C3E66B97Q58552999-099630B9-82AB-4579-8747-FF31042B8A95
P2860
The neutrophil-lymphocyte ratio and its utilisation for the management of cancer patients in early clinical trials.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The neutrophil-lymphocyte rati ...... ents in early clinical trials.
@ast
The neutrophil-lymphocyte rati ...... ents in early clinical trials.
@en
type
label
The neutrophil-lymphocyte rati ...... ents in early clinical trials.
@ast
The neutrophil-lymphocyte rati ...... ents in early clinical trials.
@en
prefLabel
The neutrophil-lymphocyte rati ...... ents in early clinical trials.
@ast
The neutrophil-lymphocyte rati ...... ents in early clinical trials.
@en
P2093
P2860
P356
P1476
The neutrophil-lymphocyte rati ...... ients in early clinical trials
@en
P2093
J S de Bono
M Guardascione
V Michalarea
P2860
P2888
P304
P356
10.1038/BJC.2015.67
P407
P577
2015-03-31T00:00:00Z